Crossmark

Androgen deprivation therapy does not increase rates for reintervention, complication, or infection in primary penile implant or artificial urinary sphincter surgery: a retrospective cohort study from the TriNetX network

Crossref DOI link: https://doi.org/10.1038/s41443-025-01015-8

Published Online: 2025-01-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Prebay, Zachary J. https://orcid.org/0000-0002-9494-9633
Fu, David

Hochberg, Aaron R. https://orcid.org/0009-0007-6752-5521
Chung, Paul H. https://orcid.org/0000-0001-9360-1400
License Information

Text and Data Mining valid from 2025-01-29

Version of Record valid from 2025-01-29
More Information

Article History

Received: 7 November 2024

Revised: 17 December 2024

Accepted: 14 January 2025

First Online: 29 January 2025

Ethical approval

: “This retrospective study is exempt from informed consent. The data reviewed is a secondary analysis of existing data, does not involve intervention or interaction with human subjects, and is de-identified per the de-identification standard defined in Section §164.514(a) of the HIPAA Privacy Rule. The process by which the data is de-identified is attested to through a formal determination by a qualified expert as defined in Section §164.514(b)(1) of the HIPAA Privacy Rule. This formal determination by a qualified expert refreshed on December 2020.” Per TriNetX publication guidelines. (, accessed January 12, 2025).

: PHC consults for and receives research support from Boston Scientific and Coloplast.

Document is current

Any future updates will be listed below